Clinical Research Directory
Browse clinical research sites, groups, and studies.
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
Sponsor: Mayo Clinic
Summary
This study characterizes deoxyribonucleic acid (DNA) and proteomic (protein) changes in both biopsies and tumors removed during surgery of patients who have been diagnosed with aggressive/metastatic (that has spread to other places in the body) cancer in order to identify possible diagnostic markers and potential drugs for treating aggressive tumor types. Proteomic analyses include looking at the proteome, or all the proteins expressed, or made by DNA at a specific moment in time. Studying samples of blood, buccal (cheek), and tissue in the laboratory from patients undergoing surgical resection or biopsy may help doctors learn more about the changes that occur in the proteome, DNA alterations, and identify molecular biomarkers for which therapeutic drugs may exist. Studying the DNA in tumor tissue and in blood may also help researchers see if the tumor has important differences.
Official title: Integrated Genomics and Patient-Derived Cancer Models
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2022-06-29
Completion Date
2028-04-07
Last Updated
2025-04-02
Healthy Volunteers
No
Interventions
Biopsy Specimen
Undergo collection of tissue samples
Biospecimen Collection
Undergo collection of blood and buccal swab samples
Biospecimen Collection
Undergo collection of archived tissue and blood samples
Medical Chart Review
Review of medical record
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States